Show simple item record

dc.contributor.authorde Assis, LJ
dc.contributor.authorUlas, M
dc.contributor.authorRies, LNA
dc.contributor.authorEl Ramli, NAM
dc.contributor.authorSarikaya-Bayram, O
dc.contributor.authorBraus, GH
dc.contributor.authorBayram, O
dc.contributor.authorGoldman, GH
dc.contributor.editorYu J-H
dc.contributor.editorBahn Y-S
dc.date.accessioned2024-02-27T13:49:16Z
dc.date.available2024-02-27T13:49:16Z
dc.date.issued2018-07-05
dc.identifier.issn2161-2129
dc.identifier.issn2150-7511
dc.identifier.otherARTN e00840-18
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/22100
dc.description.abstract

<jats:title>ABSTRACT</jats:title> <jats:p> The attachment of one or more ubiquitin molecules by SCF ( <jats:underline>S</jats:underline> kp– <jats:underline>C</jats:underline> ullin– <jats:underline>F</jats:underline> -box) complexes to protein substrates targets them for subsequent degradation by the 26S proteasome, allowing the control of numerous cellular processes. Glucose-mediated signaling and subsequent carbon catabolite repression (CCR) are processes relying on the functional regulation of target proteins, ultimately controlling the utilization of this carbon source. In the filamentous fungus <jats:named-content content-type="genus-species">Aspergillus nidulans</jats:named-content> , CCR is mediated by the transcription factor CreA, which modulates the expression of genes encoding biotechnologically relevant enzymes. Although CreA-mediated repression of target genes has been extensively studied, less is known about the regulatory pathways governing CCR and this work aimed at further unravelling these events. The Fbx23 F-box protein was identified as being involved in CCR and the Δ <jats:italic>fbx23</jats:italic> mutant presented impaired xylanase production under repressing (glucose) and derepressing (xylan) conditions. Mass spectrometry showed that Fbx23 is part of an SCF ubiquitin ligase complex that is bridged via the GskA protein kinase to the CreA-SsnF-RcoA repressor complex, resulting in the degradation of the latter under derepressing conditions. Upon the addition of glucose, CreA dissociates from the ubiquitin ligase complex and is transported into the nucleus. Furthermore, casein kinase is important for CreA function during glucose signaling, although the exact role of phosphorylation in CCR remains to be determined. In summary, this study unraveled novel mechanistic details underlying CreA-mediated CCR and provided a solid basis for studying additional factors involved in carbon source utilization which could prove useful for biotechnological applications. </jats:p> <jats:p> <jats:bold>IMPORTANCE</jats:bold> The production of biofuels from plant biomass has gained interest in recent years as an environmentally friendly alternative to production from petroleum-based energy sources. Filamentous fungi, which naturally thrive on decaying plant matter, are of particular interest for this process due to their ability to secrete enzymes required for the deconstruction of lignocellulosic material. A major drawback in fungal hydrolytic enzyme production is the repression of the corresponding genes in the presence of glucose, a process known as carbon catabolite repression (CCR). This report provides previously unknown mechanistic insights into CCR through elucidating part of the protein-protein interaction regulatory system that governs the CreA transcriptional regulator in the reference organism <jats:named-content content-type="genus-species">Aspergillus nidulans</jats:named-content> in the presence of glucose and the biotechnologically relevant plant polysaccharide xylan. </jats:p>

dc.format.extente00840-e00818
dc.format.mediumElectronic
dc.languageen
dc.publisherAmerican Society for Microbiology
dc.subjectcarbon catabolite repression
dc.subjectCreA
dc.subjectF-box
dc.subjectSCF complex
dc.subjectprotein kinase
dc.titleRegulation of <i>Aspergillus nidulans</i> CreA-Mediated Catabolite Repression by the F-Box Proteins Fbx23 and Fbx47
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29921666
plymouth.issue3
plymouth.volume9
plymouth.publisher-urlhttp://dx.doi.org/10.1128/mbio.00840-18
plymouth.publication-statusPublished
plymouth.journalmBio
dc.identifier.doi10.1128/mbio.00840-18
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
plymouth.organisational-group|Plymouth|Faculty of Health|School of Biomedical Sciences
plymouth.organisational-group|Plymouth|REF 2028 Researchers by UoA
plymouth.organisational-group|Plymouth|REF 2028 Researchers by UoA|UoA01 Clinical Medicine
dc.publisher.placeUnited States
dc.date.updated2024-02-27T13:49:15Z
dc.identifier.eissn2150-7511
dc.rights.embargoperiodforever
rioxxterms.versionofrecord10.1128/mbio.00840-18


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV